Lewis-de Los Angeles William W, Thurm Cary, Hersh Adam L, Shah Samir S, Smith Michael J, Gerber Jeffrey S, Parker Sarah K, Newland Jason G, Kronman Matthew P, Lee Brian R, Brogan Thomas V, Courter Joshua D, Spaulding Alicen, Patel Sameer J
Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois;
Children's Hospital Association, Lenexa, Kansas.
Pediatrics. 2017 Dec;140(6). doi: 10.1542/peds.2017-1021. Epub 2017 Nov 2.
To assess trends in the duration of intravenous (IV) antibiotics for urinary tract infections (UTIs) in infants ≤60 days old between 2005 and 2015 and determine if the duration of IV antibiotic treatment is associated with readmission.
Retrospective analysis of infants ≤60 days old diagnosed with a UTI who were admitted to a children's hospital and received IV antibiotics. Infants were excluded if they had a previous surgery or comorbidities, bacteremia, or admission to the ICU. Data were analyzed from the Pediatric Health Information System database from 2005 through 2015. The primary outcome was readmission within 30 days for a UTI.
The proportion of infants ≤60 days old receiving 4 or more days of IV antibiotics (long IV treatment) decreased from 50% in 2005 to 19% in 2015. The proportion of infants ≤60 days old receiving long IV treatment at 46 children's hospitals varied between 3% and 59% and did not correlate with readmission (correlation coefficient 0.13; = .37). In multivariable analysis, readmission for a UTI was associated with younger age and female sex but not duration of IV antibiotic therapy (adjusted odds ratio for long IV treatment: 0.93 [95% confidence interval 0.52-1.67]).
The proportion of infants ≤60 days old receiving long IV treatment decreased substantially from 2005 to 2015 without an increase in hospital readmissions. These findings support the safety of short-course IV antibiotic therapy for appropriately selected neonates.
评估2005年至2015年间60日龄及以下婴儿尿路感染(UTI)静脉注射(IV)抗生素的使用时长趋势,并确定IV抗生素治疗时长是否与再入院相关。
对诊断为UTI并入住儿童医院且接受IV抗生素治疗的60日龄及以下婴儿进行回顾性分析。若婴儿曾接受手术、患有合并症、菌血症或入住重症监护病房(ICU),则将其排除。分析2005年至2015年儿科健康信息系统数据库中的数据。主要结局为UTI相关的30天内再入院情况。
接受4天或更长时间IV抗生素治疗(长时IV治疗)的60日龄及以下婴儿比例从2005年的50%降至2015年的19%。46家儿童医院中接受长时IV治疗的60日龄及以下婴儿比例在3%至59%之间,且与再入院情况无关(相关系数0.13;P = 0.37)。在多变量分析中,UTI相关再入院与年龄较小和女性性别相关,但与IV抗生素治疗时长无关(长时IV治疗的调整比值比:0.93 [95%置信区间0.52 - 1.67])。
2005年至2015年间,接受长时IV治疗的60日龄及以下婴儿比例大幅下降,且医院再入院率未增加。这些发现支持了为适当选择的新生儿进行短疗程IV抗生素治疗的安全性。